MCCORMICK FRANK sold BBIO
October 27, 2025 · Form 4 insider transaction
MCCORMICK FRANK sold 1,641 shares of BridgeBio Pharma, Inc. at $65.00 per share, a transaction worth $106.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,641
Price
$65.00
Total value
$106.7K
InsiderMCCORMICK FRANK
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 27, 2025
Filing dateOctober 29, 2025
Shares owned after878,338
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 28, 2024.